NCT07466186Not yet recruiting
Resistance Training on Depression and Quality of Life in Type 1 Diabetic Women
Effect of Resistance Training on Depression and Quality of Life in Type 1 Diabetic Women
Source: ClinicalTrials.gov · Last updated 12 Mar 2026
Brief summary (registry, in English)
Find out the effects of resistance training on depression, sleep quality, and quality of life in women with type 1 diabetes mellitus
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- First submitted
- 8 Mar 2026
- Start date
- Mar 2026
- Primary completion date
- Jul 2026
- Lead sponsor
- Middle East University
- Diseases
- Type 1 diabetes
- NCT number
- NCT07466186
What you commit to
- Study type: Interventional
- Planned participants: 78
- From Mar 2026 to the primary completion date, Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of other types of diabetes, unstable cardiopulmonary conditions, recent neurological or musculoskeletal problems affecting exercise, pregnancy, postmenopausal status, and the use of sedatives or antidepressants.
Who the study is looking for
- Diagnosis of type 1 diabetes for more than 5 years
- Unchanged insulin doses for no less than three months
- Good glycemic control, defined as glycated hemoglobin levels below 7%
- Minimal to moderate depressive symptoms
- Sleep quality impairment
Age in the registry: 20 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tanta University Hospital Coordinator of this site? Confirm its status | Tanta | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.